BIO-key International (BKYI) Investor presentation summary
Event summary combining transcript, slides, and related documents.
Investor presentation summary
24 Jul, 2026Financial highlights
Recent share price at $4.60 with a 52-week range of $3.10–$19.70 and market cap of $5.1M.
Cash equivalents of $2.25M and total assets of $8.2M as of March 31, 2026.
LTM revenue of $6.5M, with 1H’26 revenue expected to increase 50% to $5M versus 1H’25.
Book value per share is $4.45, and price-to-book ratio is 1.04x.
Trades at 0.8x price/sales, below software and cybersecurity industry medians.
Product and solution overview
Offers biometric authentication, IAM platform, and passwordless solutions including PortalGuard, Passkey: YOU, and MobileAuth.
Solutions support defense-grade security, multi-factor authentication, and single sign-on.
WEB-key engine manages authentication at massive scale for use cases like passport control and voter registration.
Authentication devices include USB fingerprint scanners and FIDO security keys.
Unique phoneless/tokenless biometric authentication eliminates reliance on hardware or mobile devices.
Market drivers and regulatory landscape
EU NIS2 and Cyber Resilience Act mandate MFA and secure identity controls for critical sectors.
US regulations require secure cloud configurations, MFA, and compliance for federal agencies and defense contractors.
Cyber insurance and industry standards increasingly demand strong authentication and identity management.
Latest events from BIO-key International
- Shareholders are asked to approve warrant-related share issuance that could dilute ownership by 53.2%.BKYI
Proxy filing - Q2 2026 revenue up 13%, net loss down 51%, with record margin and EMEA-driven growth.BKYI
Q2 2026 - Proxy covers director elections, auditor change, executive pay, and governance practices.BKYI
Proxy filing - Biometric authentication growth accelerates amid regulatory demand and sustained profitability.BKYI
RedChip Future Tech Investor Conference - Q1 revenue up 34% to $2.15M; profitability and Nasdaq relisting remain key near-term issues.BKYI
Q1 2026 - 2025 revenue fell 12%, but strong Q1 2026 outlook and sector wins support 2026 growth.BKYI
Q4 2025 - Vote proposed on a reverse stock split to regain Nasdaq compliance and enhance stock value.BKYI
Proxy Filing - Vote on a reverse stock split to regain Nasdaq compliance and enhance stock marketability.BKYI
Proxy Filing - Q1 2025 saw sequential revenue growth, margin strength, and improved cash, but liquidity risks remain.BKYI
Q1 2025